BioCentury
ARTICLE | Clinical News

Cervarix regulatory update

July 25, 2016 7:00 AM UTC

The China FDA approved Cervarix HPV vaccine from GlaxoSmithKline to prevent cervical cancer in women ages 9-25. GSK plans to launch the product in China in early 2017. The HPV types 16 and 18 vaccine ...